Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023
January 03 2023 - 7:58AM
Business Wire
The showcase will highlight the benefits of
continuous patient temperature monitoring in cancer patients
Blue Spark Technologies, Inc., a leader in wearable remote
patient monitoring solutions, will showcase TempTraq® at the 2023
Consumer Electronics Show (CES) at the Las Vegas Convention Center
January 5-8. The remote patient monitoring company plans to
demonstrate its continuous temperature monitoring device as part of
the Medidata Sensor Cloud exhibit. Built within the Medidata
unified data platform, Sensor Cloud manages a broad range of
wearable sensor and digital health technology data for clinical
trials. Medidata is one of the features of the Dassault Systèmes
(Euronext Paris: FR0014003TT8, DSY.PA) presence at CES,
which is located at booth number 8705 in the digital healthcare
pavilion.
“As hospitals continue to manage nursing shortages and
fluctuations in hospital occupancy, digital health technology is
stepping up to help streamline workflows and better support patient
health,” said John Gannon, president and CEO, Blue Spark
Technologies. “Continuous temperature monitoring detects fevers
earlier, transforming today’s vital sign monitoring standards and
helping healthcare providers deliver life-saving care.”
TempTraq is a Bluetooth-enabled patch that monitors patients’
temperature continuously and alerts to temperature rise events in
real time. The comfortable, disposable patch is an FDA and CE
Cleared Class II medical device that goes beyond the current
standard of care, providing clinicians a quicker, easier, and more
effective way to continuously measure temperature in inpatient and
outpatient settings.
In 2022, TempTraq joined the Medidata Sensor Cloud Network to
support the adoption of medical sensors in clinical and
pharmaceutical medical research with data integration and
standardization.
“Having TempTraq with us at CES helps to underscore the
overarching objective at Dassault Systèmes to bring together
multiple disciplines to accelerate sustainable innovation and human
health,’ said Ben Schlatka, vice president, Digital Biomarker
Solutions at Medidata. “Blue Spark is a valuable member of the
growing Sensor Cloud Network, helping to shape the future of
patient data collection and analysis.”
Medidata is a wholly owned subsidiary of Dassault Systèmes.
About Blue Spark Technologies
Founded in Westlake, Ohio, Blue Spark Technologies is dedicated
to pioneering continuous vital sign monitoring solutions that
improve patient care, reduce costs and readmissions, and optimize
hospital reimbursement. Its medical devices contain no hazardous
substances, making them safe, disposable, and eco-friendly. Blue
Spark’s flagship product, TempTraq®, is the only continuous,
disposable adhesive patch for real-time body temperature
monitoring, clinically proven to detect fevers earlier than the
standard of care for up to 72 hours. The comfortable, wireless
TempTraq sensor transmits data via Bluetooth®. As an FDA Cleared
Class-II, EU-Cleared Class II, and HIPAA-compliant medical device,
it can upload real-time data to the TempTraq Connect platform,
which integrates seamlessly into a hospital’s central monitoring
station or can be accessed in outpatient settings via Apple® or
Android™ compatible mobile devices. Through continuous monitoring,
TempTraq improves the way healthcare professionals monitor for
fever, providing a simple, effective way to elevate the standard of
care delivered in the clinical environment. For more information
about TempTraq®, visit https://temptraq.healthcare.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230103005451/en/
Linda Healan CG Life 404-725-7117 Lhealan@cglife.com
Destiny Media Technologies (TSXV:DSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Destiny Media Technologies (TSXV:DSY)
Historical Stock Chart
From Apr 2023 to Apr 2024